Cvs Health (CVS) Net Income towards Common Stockholders (2009 - 2026)

Cvs Health's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $3.0 billion for Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 65.94% year-over-year to $3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (down 44.64% YoY) and the FY2025 annual result came in at $1.7 billion, down 62.32% from the prior year.
• Net Income towards Common Stockholders was $3.0 billion for Q1 2026 at Cvs Health, up from $2.9 billion in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $3.0 billion in Q2 2022 and bottomed at -$4.0 billion in Q3 2025.
• A 5-year average of $1.3 billion and a median of $1.9 billion in 2023 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 166.64% — and 2025, when it tumbled 5719.72%.
• Cvs Health's Net Income towards Common Stockholders stood at $2.3 billion in 2022, then fell by 12.22% to $2.0 billion in 2023, then decreased by 20.71% to $1.6 billion in 2024, then soared by 80.1% to $2.9 billion in 2025, then climbed by 1.16% to $3.0 billion in 2026.
• Business Quant data shows CVS's Net Income towards Common Stockholders at $3.0 billion in Q1 2026, $2.9 billion in Q4 2025, and -$4.0 billion in Q3 2025.